Since high levels of NT5E/CD73 expression on tumor cells are significantly associated with reduced disease free survival (DFS) and overall survival (OS), and negatively correlate with tumor infiltration by immune cells, NT5E/CD73 targeting could be a promising strategy to reprogram the TME (Buisseret et al., 2018). This evidence concerns the gene NT5E and neoplasm.